NCT00005814View on ClinicalTrials.gov

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

cisplatin

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005814 - Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer | Biotech Hunter | Biotech Hunter